Status:
NOT_YET_RECRUITING
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
Lead Sponsor:
University of Bologna
Conditions:
Cardiovascular Prevention
Diabetes Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Low-glycemic index (GI) carbohydrates help prevent type 2 diabetes and cardiovascular disease by reducing postprandial glucose, insulin spikes, inflammation, and triglyceride synthesis. They improve w...
Detailed Description
The consumption of carbohydrates with a low glycemic index (GI) has emerged as a cornerstone in the dietary prevention of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). The glycemic...
Eligibility Criteria
Inclusion
- Male or female aged ≥ 18 years
- TG\>150 mg/dL
- Subjects who have the capability to communicate and to comply with the study's requirements.
- Subjects agree to participate in the study and having dated and signed the informed consent form.
Exclusion
- Gluten hypersensitivity/Coeliac disease diagnosis
- BMI\>30 kg/m2
- Any preventive treatments (i.e. lipid-lowering drugs, antihypertensives) not stabilized in type and dose for at least 3 months
- Any medical or surgical condition that would limit the patient adhesion to the study protocol.
Key Trial Info
Start Date :
October 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 29 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07198789
Start Date
October 30 2025
End Date
May 29 2026
Last Update
September 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.